Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system

Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system

Abstract Background Degenerative cervical myelopathy (DCM) is caused by degenerative or congenital changes to the discs and soft tissues of the cervical spine, which leads to chronic compression of the spinal cord. The current treatment for moderate to severe DCM consists of surgical decompression,...

Full description

Bibliographic Details
Main Authors: Pia M. Vidal, Antigona Ulndreaj, Anna Badner, James Hong, Michael G. Fehlings
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Journal of Neuroinflammation
Subjects:
Degenerative cervical myelopathy
Methylprednisolone
Surgical decompression
Neuroinflammation
Immunosuppression
Online Access:http://link.springer.com/article/10.1186/s12974-018-1257-7

Internet

http://link.springer.com/article/10.1186/s12974-018-1257-7

Similar Items